An historical perspective of multi-modality treatment for resectable non-small cell lung cancer (Q40408812)

20 September 2017

1 reference

title

An historical perspective of multi-modality treatment for resectable non-small cell lung cancer (English)

1 reference

20 September 2017

Jaklitsch MT

1 reference

20 September 2017

Strauss GM

1 reference

20 September 2017

Healey EA

1 reference

20 September 2017

DeCamp MM Jr

1 reference

20 September 2017

Liptay MJ

1 reference

20 September 2017

Sugarbaker DJ

1 reference

20 September 2017

publication date

1 June 1995

1 reference

20 September 2017

1 reference

20 September 2017

volume

12 Suppl 2

1 reference

20 September 2017

page(s)

S17-32

1 reference

20 September 2017

cites work

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Diagnostic criteria and technology as sources for changing incidences of pulmonary diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Survival in primary carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

A method of biopsy useful in diagnosing certain intrathoracic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

A simple cervicomediastinal exploration for tissue diagnosis of intrathoracic disease; with comments on the recognition of inoperable carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Mediastinoscopy: a method for inspection and tissue biopsy in the superior mediastinum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Diagnostic anterior mediastinotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

American Thoracic Society. Medical section of the American Lung Association. Clinical staging of primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

A new international staging system for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Radiotherapy of cancer of the lung; results in a selected group of cases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Treatment of inoperable cancer of the bronchus by megavoltage x-ray therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Inoperable cancer of the bronchus treated by megavoltage x-ray therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Combined radiotherapy and resection for carcinoma of the bronchus; experiences with 66 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Nitrogen mustard in treatment of bronchial carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Nitrogen mustard in treatment of advanced carcinoma of lung; analysis of one hundred ninety-eight cases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Tumor Stage in Non-Small Cell Carcinoma of the Lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Treatment of stage II lung cancer (T1N1 and T2N1).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

The role of surgery in N2 lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Multimodality therapy for stage IIIA (N2) lung cancer. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Preoperative radiation therapy in the treatment of bronchial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Preoperative irradiation of cancer of the lung: Final report of a therapeutic trial.A collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: a phase II study of the Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Neoadjuvant therapy: a novel and effective treatment for stage IIIb non-small cell lung cancer. Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

Stage IIIA category of non-small-cell lung cancer: a new proposal.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2810%2980003-0

7 January 2021

10.1016/S0169-5002(10)80003-0

Identifiers

DOI

0 references

1 reference